Want to join the conversation?
$SJM 1Q16 Call: Our full-year estimate for free cash flow has increased from $850-900MM, assuming CapEx of $200MM. We expect the YoverY EPS growth to fall in the back half of fiscal year. We anticipate second quarter results to be slightly behind last year, primarily due to planned significant increase in margin expenses in support of our brands.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.